AVEO Oncology Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Conference Call

  AVEO Oncology Announces Timing for Fourth Quarter and Year-End 2012
  Financial Results Conference Call

Business Wire

CAMBRIDGE, Mass. -- January 31, 2013

AVEO Oncology (NASDAQ:AVEO) today announced that financial results for the
company’s fourth quarter and year ended December 31, 2012 will be released
before the market opens on Wednesday, February 13, 2013. The AVEO management
team will host a conference call discussing the company’s financial results,
recent developments and detailed TIVO-1 findings on Wednesday, February 13,
2013 at 10:00 a.m. (ET). The call can be accessed by dialing 1-866-831-6243
(domestic) or 1-617-213-8855 (international) five minutes prior to the start
of the call and providing the passcode 81400823. A replay of the call will be
available approximately two hours after the completion of the call and can be
accessed by dialing 1-888-286-8010 (domestic) or 1-617-801-6888
(international), providing the passcode 61126312. The replay will be available
for two weeks from the date of the live call.

The live webcast of the conference call can be accessed by visiting the
investors section of the AVEO website at investor.aveooncology.com. A replay
of the webcast will be archived on the AVEO website for two weeks following
the call.

About AVEO

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to
discovering, developing and commercializing targeted therapies to impact
patients’ lives. AVEO’s proprietary Human Response Platform™ provides the
company unique insights into cancer biology and is being leveraged in the
discovery and clinical development of its cancer therapeutics. For more
information, please visit the company’s website at www.aveooncology.com.

Contact:

AVEO Oncology
Investor Contact:
Monique Allaire, 617-299-5810
or
Media Contact:
Rob Kloppenburg, 617-930-5595
 
Press spacebar to pause and continue. Press esc to stop.